Acceso usuarios
* A new ventricular assist device designed for use in children with heart failure resulted in significantly higher survival than did extracorporeal membrane oxygenation during the bridge to transplantation.
* Serious adverse events, such as bleeding, injection, and stroke, were common in all participants.
